Virus-mediated decrease of LKB1 activity in the mPFC diminishes stress-induced depressive-like behaviors in mice

Area of Science:

• Neuroscience
• Molecular Biology
• Psychiatry

Background:

• Depression is a prevalent neuropsychiatric disorder with complex pathophysiology, where chronic stress plays a critical role.
• The central mammalian target of rapamycin complex 1 (mTORC1) signaling pathway is implicated in depression, but the mechanism by which chronic stress affects it remains unclear.
• Liver kinase b1 (LKB1) regulates mTORC1 activity via AMP-activated protein kinase (AMPK), suggesting a potential link to stress-induced depression.

Purpose of the Study:

• To investigate whether LKB1 in the medial prefrontal cortex (mPFC) mediates the effects of chronic stress on depression via the AMPK-mTORC1 signaling pathway.
• To explore LKB1 as a potential therapeutic target for depression and stress-related disorders.

Main Methods:

• Utilized mouse models of depression induced by chronic stress.
• Employed western blotting and immunofluorescence techniques to analyze protein expression and localization.
• Performed genetic knockdown of LKB1 in the mPFC of mice.

Main Results:

• Chronic stress significantly increased both total and phosphorylated LKB1 expression in the mPFC, but not the hippocampus.
• Genetic knockdown of LKB1 in the mPFC reversed stress-induced depressive-like behaviors in mice.
• LKB1 knockdown also normalized the effects of chronic stress on AMPK and mTORC1 signaling in the mPFC.

Conclusions:

• LKB1 in the mPFC plays a crucial role in the development of depressive-like behaviors under chronic stress conditions.
• LKB1 in the mPFC represents a potential therapeutic target for antidepressant development.
• Inhibition of LKB1 may be a viable strategy for treating chronic stress-related neuropsychiatric disorders.